| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to community-based lung cancer screening in the Yorkshire Lung Screening Trial
|
Ahmad, Sarah Q.
|
|
|
200 |
C |
p.
|
artikel
|
| 2 |
Artificial intelligence for diagnosis and predictive biomarkers in Non-Small cell lung cancer Patients: New promises but also new hurdles for the pathologist
|
Hofman, Paul
|
|
|
200 |
C |
p.
|
artikel
|
| 3 |
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer
|
Saw, Stephanie P.L.
|
|
|
200 |
C |
p.
|
artikel
|
| 4 |
Association of single nucleotide polymorphisms rs7459185 of the HSPβ1 gene and the risk of hematological toxicity in lung cancer
|
Muñoz, Óscar Muñoz
|
|
|
200 |
C |
p.
|
artikel
|
| 5 |
Clinical utility of comprehensive genomic profiling in non-small cell lung cancer: An analysis of a nation-wide database
|
Fujii, Koki
|
|
|
200 |
C |
p.
|
artikel
|
| 6 |
Comparative analysis of first-line treatment in NSCLC including unresectable stage III (IIIB/IIIC) and stage IV with low PD-L1 expression: Clinical trial eligible versus ineligible patients
|
Hata, Tae
|
|
|
200 |
C |
p.
|
artikel
|
| 7 |
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking
|
Reuss, Joshua E.
|
|
|
200 |
C |
p.
|
artikel
|
| 8 |
Contents
|
|
|
|
200 |
C |
p.
|
artikel
|
| 9 |
Diagnostic and prognostic relevance of inflammatory markers in surgically treated thymic epithelial tumors: An international multicenter study
|
Megyesfalvi, Evelyn
|
|
|
200 |
C |
p.
|
artikel
|
| 10 |
Dynamic characterization of circulating tumor DNA in HER2-altered advanced non-small cell lung cancer treated with pyrotinib and apatinib: Exploratory biomarker analysis from PATHER2 study
|
Dong, Yucheng
|
|
|
200 |
C |
p.
|
artikel
|
| 11 |
First-line osimertinib compared to earlier generation TKIs in advanced EGFR-mutant NSCLC: A real-world survival analysis
|
Gomez-Randulfe, Igor
|
|
|
200 |
C |
p.
|
artikel
|
| 12 |
Health-related quality of life and symptoms in patients with previously untreated, locally advanced or metastatic non-squamous non-small cell lung cancer treated with sintilimab or placebo plus pemetrexed and platinum (ORIENT-11): A randomized, double-blind, phase 3 trial
|
Liu, Tingting
|
|
|
200 |
C |
p.
|
artikel
|
| 13 |
Histological and genetic features and therapeutic responses of lung cancers explored via the global analysis of their metabolome profile
|
Narita, Daisuke
|
|
|
200 |
C |
p.
|
artikel
|
| 14 |
Rearranged during transfection (RET) lung cancer – Update on targeted therapies
|
Mullally, W.J.
|
|
|
200 |
C |
p.
|
artikel
|
| 15 |
Survival benefit and potential markers of chemotherapy for elderly and poor performance status patients with advanced non-small cell lung cancer: Results from the Japanese Joint Committee of lung cancer registry database
|
Ikeda, Satoshi
|
|
|
200 |
C |
p.
|
artikel
|
| 16 |
Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert group
|
Decoster, L.
|
|
|
200 |
C |
p.
|
artikel
|
| 17 |
Validation of the 9th edition of the TNM staging system for limited-stage small cell lung cancer after Resection: A multicenter study
|
Wu, Leilei
|
|
|
200 |
C |
p.
|
artikel
|
Tijdschrift beschrijving